These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 3623742)

  • 21. [Pharmacokinetics of alpha-acetyldigoxin. Studies on normal subjects after oral application].
    Lücker PW; Simon B; Wetzelsberger K
    Arzneimittelforschung; 1978; 28(10):1781-7. PubMed ID: 582684
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinico-pharmacological and clinical evaluation of pengitoxin].
    Haustein KO; Wesser M
    Farmakol Toksikol; 1982; 45(3):67-8. PubMed ID: 7095131
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pharmacokinetic study of a cephalosporin, cefoperazone, in liver failure].
    Belaieff J; Cochet B; Allaz AF; Rudhardt M; Balant L; Fabre J
    Schweiz Med Wochenschr; 1981 Apr; 111(14):502-8. PubMed ID: 6453423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic investigations with 3H-penta-acetyl-gitoxin in volunteers and patients with respect to the occurrence of drug latentiation.
    Haustein KO; Pachaly C; Murawski D
    Int J Clin Pharmacol Biopharm; 1978 Jun; 16(6):285-9. PubMed ID: 669874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of cholestyramine in three patients with beta-acetyldigoxin, beta-methyldigoxin and digitoxin intoxication.
    Kuhlmann J
    Int J Clin Pharmacol Ther Toxicol; 1984 Oct; 22(10):543-8. PubMed ID: 6511130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of voriconazole during continuous venovenous haemodiafiltration.
    Fuhrmann V; Schenk P; Jaeger W; Miksits M; Kneidinger N; Warszawska J; Holzinger U; Kitzberger R; Thalhammer F
    J Antimicrob Chemother; 2007 Nov; 60(5):1085-90. PubMed ID: 17855725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of brodimoprim in special populations.
    Stockis A; Borzio F; Deroubaix X; Gaspari F; Jeanbaptiste B; Lebacq E; Lins R; Pavesio D; Pelozi GC; Rosillon D
    J Chemother; 1993 Dec; 5(6):480-7. PubMed ID: 8195841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary sodium balance in patients with cirrhosis: relationship to quantitative parameters of liver function.
    Wensing G; Lotterer E; Link I; Hahn EG; Fleig WE
    Hepatology; 1997 Nov; 26(5):1149-55. PubMed ID: 9362355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of levetiracetam in patients with moderate to severe liver cirrhosis (Child-Pugh classes A, B, and C): characterization by dynamic liver function tests.
    Brockmöller J; Thomsen T; Wittstock M; Coupez R; Lochs H; Roots I
    Clin Pharmacol Ther; 2005 Jun; 77(6):529-41. PubMed ID: 15961984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of oxaliplatin in patients with severe hepatic dysfunction.
    Baur M; Drescher A; Gneist M; Dittrich C; Jaehde U
    Cancer Chemother Pharmacol; 2008 Jan; 61(1):97-104. PubMed ID: 17396265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of valsartan in patients with liver disease.
    Brookman LJ; Rolan PE; Benjamin IS; Palmer KR; Wyld PJ; Lloyd P; Flesch G; Waldmeier F; Sioufi A; Mullins F
    Clin Pharmacol Ther; 1997 Sep; 62(3):272-8. PubMed ID: 9333102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acetaminophen plasma level after oral administration in liver cirrhotic patients suffering from schistosomal infection.
    el-Azab G; Youssef MK; Higashi Y; Murakami T; Yata N
    Int J Clin Pharmacol Ther; 1996 Jul; 34(7):299-303. PubMed ID: 8832306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Plasma concentration and elimination behavior of the cardiac glycoside meproscillarin in patients with liver cirrhosis].
    Burkert K; Beckmann H
    Z Gastroenterol; 1983 Jan; 21(1):34-40. PubMed ID: 6845784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma pharmacokinetics of adriamycin and antipyrine and its relation to the therapeutic and toxic effects.
    Preiss R; Matthias M; Sohr R; Brockmann B; Hüller H
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S79-88. PubMed ID: 3842695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Marked prolongation in disappearance half-time of plasma cholecystokinin-octapeptide in patients with hepatic cirrhosis.
    Kanayama S; Himeno S; Kurokawa M; Shinomura Y; Kuroshima T; Okuno M; Tsuji K; Higashimoto Y; Ikei N; Hashimura E
    Am J Gastroenterol; 1985 Jul; 80(7):557-60. PubMed ID: 4014106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Changes in beta acetyldigoxin resorption following administration of beta-sitosterine or cholestyramine].
    Schwartzkopff W; Jantke HJ
    Med Welt; 1980 Aug; 31(33):1183-8. PubMed ID: 7421554
    [No Abstract]   [Full Text] [Related]  

  • 37. Digoxin concentration in cerebrospinal fluid-a study carried out after 9 days of treatment of beta-methyldigoxin or beta-acetyldigoxin.
    Bonelli J; Rameis H; Waginger H
    Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):93-5. PubMed ID: 7228456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Normal metabolism of morphine in cirrhosis.
    Patwardhan RV; Johnson RF; Hoyumpa A; Sheehan JJ; Desmond PV; Wilkinson GR; Branch RA; Schenker S
    Gastroenterology; 1981 Dec; 81(6):1006-11. PubMed ID: 7286578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic clearance of gitoxin: pharmacokinetic study on rabbit isolated liver. Influence of protein binding and comparison with digoxin.
    Pellegrin P; Lesne M
    Eur J Drug Metab Pharmacokinet; 1983; 8(1):1-8. PubMed ID: 6861790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A further study of the pharmacokinetics of gitoxin in rabbit isolated liver: clearance of 3H-gitoxin.
    Pellegrin PL; Lesne M
    Eur J Drug Metab Pharmacokinet; 1985; 10(2):113-20. PubMed ID: 4043140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.